A clinical trial referencing bradykinin was updated in the ClinicalTrials.gov registry on September 2, 2026. The study, titled "Evaluation Of The Effect Of Low-Level Laser Therapy On Masseter Muscle Versus Therapeutic Ultrasound On Patients With Myofascial Pain Disorder: A Randomized Clinical Trial," is registered under identifier NCT07800338.
The trial's current status is listed as not yet recruiting, and it does not have an assigned phase, consistent with a study design that is not phase-based. No participants have been enrolled at this stage, and no results have been posted.
Bradykinin's regulatory status remains unapproved and it is currently used in research settings only. This update reflects only the administrative status of the trial registration and does not indicate any outcome, efficacy, or safety finding related to bradykinin or the interventions being studied.
As the trial has not yet begun recruiting, no further details on participant outcomes or comparative effects between low-level laser therapy and therapeutic ultrasound are available at this time. Interested readers can monitor the registry listing for future updates as the study status changes.
For more background on this compound, see the linked overview page.